BioMed Central Blog

Hereditary Cancer in Clinical Practice joins BioMed Central

The launch of Hereditary Cancer in Clinical Practice marks the third journal to transfer to BioMed Central’s open access publishing platform this year. The move benefits both authors and readers of Hereditary Cancer in Clinical Practice with increased visibility and comprehensive indexing. This will complement the exposure generated from the journal’s recent acceptance for tracking by Thomson Reuters (Impact Factor due 2010).

Hereditary Cancer in Clinical Practice first began publishing in 2003 and remains under the auspices of the International Union Against Cancer. Led by Editors-in-Chief, Jan Lubiński, Rodney J. Scott and Rolf Sijmons, the journal continues to provide a discussion forum for the development of appropriate health care strategies for cancer genetics. The first articles published with BioMed Central reflect this cause. Dr Inmyanitov and colleagues present a case report of genetic testing for BRCA1 mutations, while Professor Scott’s team look for a possible association between MUTYH genetic variation and colorectal and endometrial cancers.

If you are interested in this area of research and would like to receive regular emails detailing the most recently published articles then please sign up for article alerts.

Posted by Anne Braae at 16:40    Comments (0)